Literature DB >> 3060241

Practical diagnostic testing for human immunodeficiency virus.

J B Jackson1, H H Balfour.   

Abstract

Since the discovery of human immunodeficiency virus (HIV) as the causative agent of acquired immunodeficiency syndrome in 1983, there has been a proliferation of diagnostic tests. These assays can be used to detect the presence of HIV antibody, HIV antigen, HIV ribonucleic and deoxyribonucleic acids, and HIV reverse transcriptase. Enzyme-linked immunosorbent assays, Western blot, radioimmunoprecipitation assays, indirect immunofluorescence assays, reverse transcriptase assays, and several molecular hybridization techniques are currently available. Enzyme-linked immunosorbent, Western blot, and indirect immunofluorescence assays for HIV antibody are very sensitive, specific, and adaptable to most laboratories. An enzyme-linked immunosorbent assay for HIV antigen is also readily adaptable to most laboratories and will be commercially available soon. While the other assays are more tedious, they are valuable confirmatory tests and are suitable for reference laboratories. The biohazards of performing HIV testing can be minimized with proper biosafety measures.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3060241      PMCID: PMC358034          DOI: 10.1128/CMR.1.1.124

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  111 in total

1.  Occupational risk of the acquired immunodeficiency syndrome among health care workers.

Authors:  E McCray
Journal:  N Engl J Med       Date:  1986-04-24       Impact factor: 91.245

2.  Screening for HIV: can we afford the false positive rate?

Authors:  K B Meyer; S G Pauker
Journal:  N Engl J Med       Date:  1987-07-23       Impact factor: 91.245

3.  Safety issues raised by worker's infection with AIDS virus.

Authors:  J Palca
Journal:  Nature       Date:  1987 Sep 17-23       Impact factor: 49.962

4.  Sensitivity of western blotting (compared with ELISA and immunofluorescence) during seroconversion after HTLV-III infection.

Authors:  J C Ulstrup; K Skaug; K J Figenschau; I Orstavik; J N Bruun; G Petersen
Journal:  Lancet       Date:  1986-05-17       Impact factor: 79.321

5.  Transfusion-associated hepatitis and AIDS. What is the risk?

Authors:  J R Bove
Journal:  N Engl J Med       Date:  1987-07-23       Impact factor: 91.245

6.  Predictive value of a screening test for antibodies to HTLV-III.

Authors:  S L Sivak; G P Wormser
Journal:  Am J Clin Pathol       Date:  1986-06       Impact factor: 2.493

7.  Acquired immunodeficiency syndrome in low-incidence areas. How safe is unsafe sex?

Authors:  D W Fleming; S L Cochi; R S Steece; H F Hull
Journal:  JAMA       Date:  1987-08-14       Impact factor: 56.272

8.  Radioimmunoprecipitation and Western blotting with sera of human immunodeficiency virus infected patients: a comparative study.

Authors:  F Chiodi; U Bredberg-Råden; G Biberfeld; B Böttiger; J Albert; B Asjö; E M Fenyö; E Norrby
Journal:  AIDS Res Hum Retroviruses       Date:  1987       Impact factor: 2.205

9.  Correlation of serum HIV antigen and antibody with clinical status in HIV-infected patients.

Authors:  D A Paul; L A Falk; H A Kessler; R M Chase; B Blaauw; D S Chudwin; A L Landay
Journal:  J Med Virol       Date:  1987-08       Impact factor: 2.327

10.  Long latency precedes overt seroconversion in sexually transmitted human-immunodeficiency-virus infection.

Authors:  A Ranki; S L Valle; M Krohn; J Antonen; J P Allain; M Leuther; G Franchini; K Krohn
Journal:  Lancet       Date:  1987-09-12       Impact factor: 79.321

View more
  18 in total

1.  Improved immunoblotting for the detection and quantitative analysis of antibodies to human immunodeficiency virus.

Authors:  P Portincasa; G Conti; M Gerloni; C Chezzi
Journal:  Eur J Epidemiol       Date:  1991-11       Impact factor: 8.082

Review 2.  Immunoserology of infectious diseases.

Authors:  K James
Journal:  Clin Microbiol Rev       Date:  1990-04       Impact factor: 26.132

Review 3.  Rapid viral diagnosis in perspective.

Authors:  P C Lee; P Hallsworth
Journal:  BMJ       Date:  1990-06-02

4.  Diagnosis of herpes simplex virus infection in a clinical setting by a direct antigen detection enzyme immunoassay kit.

Authors:  A Dascal; J Chan-Thim; M Morahan; J Portnoy; J Mendelson
Journal:  J Clin Microbiol       Date:  1989-04       Impact factor: 5.948

5.  FALSE POSITIVE ELISA RESULTS IN HUMAN IMMUNODEFICIENCY VIRUS INFECTION: A Case Report.

Authors:  Mkk Rao; R M Gupta; S K Sayal; V C Ohri; S K Kher
Journal:  Med J Armed Forces India       Date:  2017-06-26

6.  Beta 2-microglobulin and neopterin: predictive markers for human immunodeficiency virus type 1 infection in children?

Authors:  M M Chan; J M Campos; S Josephs; N Rifai
Journal:  J Clin Microbiol       Date:  1990-10       Impact factor: 5.948

7.  Immunoprecipitation of human immunodeficiency virus type 2 glycoproteins by sera positive for human immunodeficiency virus type 1.

Authors:  R T Espejo; P Uribe
Journal:  J Clin Microbiol       Date:  1990-09       Impact factor: 5.948

Review 8.  Use of virologic assays for detection of human immunodeficiency virus in clinical trials: recommendations of the AIDS Clinical Trials Group Virology Committee.

Authors:  S Hammer; C Crumpacker; R D'Aquila; B Jackson; J Lathey; D Livnat; P Reichelderfer
Journal:  J Clin Microbiol       Date:  1993-10       Impact factor: 5.948

9.  Immunofluorescence assay for human immunodeficiency virus antibody: investigation of cell fixation for virus inactivation and antigen preservation.

Authors:  M Fauvel; G Ozanne
Journal:  J Clin Microbiol       Date:  1989-08       Impact factor: 5.948

10.  Advantages of a human immunodeficiency virus type 1 (HIV-1) persistently infected HeLa T4+ cell line for HIV-1 indirect immunofluorescence serology.

Authors:  B Forghani; J W Hurst; C S Chan
Journal:  J Clin Microbiol       Date:  1991-10       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.